Tocotrienol in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review
Open Access
Abstract
The increasing burden of nonalcoholic fatty liver disease (NAFLD) requires innovative management strategies, but an effective pharmacological agent has yet to be found. Apart from weight loss and lifestyle adjustments, one isomer of the vitamin E family—alpha-tocopherol—is currently recommended for nondiabetic steatohepatitis patients. Another member of the vitamin E family, tocotrienol (T3), has anti-inflammatory and antioxidant properties that reach beyond those of alpha-tocopherol, making it a potential agent for use in NAFLD management. This systematic review aimed to provide an overview of the effects of T3 supplementation on NAFLD from both clinical and preclinical perspectives. A literature search was performed in October 2022 using PubMed, Scopus and Web of Science. Original research articles reporting NAFLD outcomes were included in this review. The search located 12 articles (8 animal studies and 4 human studies). The literature reports state that T3 isomers or natural mixtures (derived from palm or annatto) improved NAFLD outcomes (liver histology, ultrasound or liver profile). However, the improvement depended on the severity of NAFLD, study period and type of intervention (isomers/mixture of different compositions). Mechanistically, T3 improved lipid metabolism and prevented liver steatosis, and reduced mitochondrial and endoplasmic reticulum stress, inflammation and ultimately liver fibrosis. In summary, T3 could be a potential agent for use in managing NAFLD, pending more comprehensive preclinical and human studies.Keywords
Funding Information
- Universiti Kebangsaan Malaysia (GUP-2020-021)
This publication has 82 references indexed in Scilit:
- Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trialNutrition Journal, 2013
- Bile Acid Metabolism and Signaling2013
- Effects of tocotrienol on tumor necrosis factor-α/D-galactosamine-induced steatohepatitis in ratsJournal of Clinical Biochemistry and Nutrition, 2013
- Adipokines Mediate Inflammation and Insulin ResistanceFrontiers in Endocrinology, 2013
- Vitamin E as an Antiosteoporotic Agent via Receptor Activator of Nuclear Factor Kappa-B Ligand Signaling Disruption: Current Evidence and Other Potential Research AreasEvidence-Based Complementary and Alternative Medicine, 2012
- Subacute and Subchronic Toxicity Studies of Palm Vitamin E in MiceJournal of Pharmacology and Toxicology, 2011
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Liver fibrosisJournal of Clinical Investigation, 2005
- Identification and estimation of tocotrienols in the annatto lipid fraction by gas chromatography‐mass spectrometryJournal of the American Oil Chemists' Society, 1998
- Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienolFree Radical Biology and Medicine, 1991